NasdaqGM - Delayed Quote USD
Translational Development Acquisition Corp. (TDAC)
10.19
0.00
(0.00%)
At close: April 30 at 4:00:00 PM EDT
Breakdown
TTM
12/31/2024
12/31/2023
Operating Expense
196.36
196.36
485.55
Operating Income
-196.36
-196.36
-485.55
Other Income Expense
125.35
125.35
--
Pretax Income
-71.01
-71.01
-485.55
Net Income Common Stockholders
-71.01
-71.01
-485.55
Diluted NI Available to Com Stockholders
-71.01
-71.01
-485.55
Basic EPS
-0.02
--
-0.11
Diluted EPS
-0.02
--
-0.11
Basic Average Shares
4,392.47
--
4,392.47
Diluted Average Shares
4,988.32
--
19,050
Total Operating Income as Reported
-196.36
-196.36
--
Total Expenses
196.36
196.36
485.55
Net Income from Continuing & Discontinued Operation
-71.01
-71.01
-485.55
Normalized Income
-196.36
-196.36
-485.55
EBIT
-196.36
-196.36
-485.55
EBITDA
-196.36
-196.36
-485.55
Net Income from Continuing Operation Net Minority Interest
-71.01
-71.01
-485.55
Total Unusual Items Excluding Goodwill
125.35
125.35
--
Total Unusual Items
125.35
125.35
--
Normalized EBITDA
-321.70
-321.70
-485.55
12/31/2023 - 2/13/2025
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade